| Reduced Risk Status: |
|
| IPM Compatibility: |
PER REQUESTER: GOOD IPM FIT; GOOD IMP FIT; RELATIVELY NONTOXIC TO BENEFICIALS:07/20
|
| Reasons for need: |
FUSARIUM; VERY LIMITED NUMBER OF FUNGICIDES REGISTERED FOR FUSARIUM CONTROL ON BASIL; PER OR ME-TOO REQUEST 08/20: FUSARIUM WILT IS A SIGNIFICANT PROBLEM IN OR, AND ADDITIONAL ROTATION PRODUCTS WOULD BE NICE TO HAVE
|
| Requesting State(s): |
IL:DeYoung, A* ; OR:Lightle, D ; TX:Cochran, K ;
|
| PCR Use Pattern: |
USE THE MIRAVIS PRIME PRODUCT; MAKE 2 DRENCH APPLIC OF 13.4 FL OZ/100 GAL, 7-DAY INTERVAL, 0-DAY PHI; MAKE AN IN-TRAY DRENCH APPLIC FOLLOWED BY AN IN-FIELD DRENCH APPLIC FOR TRANSPLANTS; OR MAKE 2 IN-FIELD DRENCH APPLIC FOR DIRECT SEEDED BASIL
|
| EPA Default Residue Trials: |
ANY 4
|
| IR-4 Residue Trial Plan: |
ANY 4; FRESH AND DRIED
|
| Residue Protocol Use Pattern: |
USE THE MIRAVIS PRIME PRODUCT (1.25 LB AI OF PYDIFLUMETOFEN AND 2.09 LB AI OF FLUDIOXONIL ACTIVE INGREDIENTS/GAL OF PRODUCT); MAKE 3 APPLIC OF TEST SUBSTANCE; 1ST APPLIC IS 396 ML PRODUCT/A DIRECTED TO THE SOIL, IN 20-50 GPA; FOLLOW THIS 14 DAYS LATER WITH 2 FOLIAR BROADCAST APPLIC OF 342 ML/A, 7-DAY INTERVAL, IN 20-50 GPA, WITH LAST APPLIC ON THE DAY OF HARVEST (0-DAY PHI)
|
| Efficacy/Crop Safety (E/CS) Data Required: |
SOME NJ EFFICACY DATA FROM 2019 AND 2020 WILL BE AVAILABLE:07/20
|
| E/CS Research Comments: |
IN THE PERFORMANCE PROTOCOL FOR 2023: EVALUATING PRODUCT PERFORMANCE ON COMMERCIAL VARIETIES SUSCEPTIBLE TO FUSARIUM WILT; TESTING SOIL DRENCH APPLIC OF 15.4 FL OZ/A OF MIRAVIS PRIME (PYDIFLUMETOFEN + FLUDIOXONIL) VS A LABELED RATE OF A STANDARD (APPLY PER LABEL DIRECTIONS); MAKE IN-FIELD DRENCH, BANDED OR HIGH VOLUME SOIL DIRECTED SPRAY, WITH 1ST APPLIC AT TRANSPLANTING OR AT PLANTING IF SEEDED, AND 2ND APPLIC 7 DAYS LATER; 0-DAY PHI; EVALUATE FUSARIUM WILT DISEASE INCIDENCE AND SEVERITY AND CROP SAFETY; 2024 PROTOCOL FOLLOWS THE DETAILS OF THE 2023 PROTOCOL
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
GREEN(BOTH):08/21, 08/22
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
CANADA NOTED AS A KEY EXPORT MARKET; NO HERB OR BASIL TOLERANCES ARE ESTABLISHED FOR PYDIFLUMETOFEN, BUT THERE IS AN HERB 19A AND 19B TOLERANCE FOR FLUDIOXONIL (FROM WORK DONE TO REGISTER THE SWITCH LABEL, FLUDI + CYPRODINIL); IS A POTENTIAL JOINT PROJECT WITH CANADA:07/20; SYNG SUPPORTS, RESIDUE AND E/CS DATA NEEDED:09/20; EPA GREEN(BOTH):08/21, 08/22
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|